- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Mar 31, 2025 | 562.5M sh |
| Long Term Debt | Q2 2025 · Mar 31, 2025 | $8.18B |
| Long Term Debt | Q2 2025 · Sep 30, 2024 | $7.16B |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $6.19B |
| Short Term Debt | Q2 2025 · Sep 30, 2024 | $532M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $19.25B |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $21.64B |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $10.85B |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $5.74B |
| Current Assets | Q2 2025 · Mar 31, 2025 | $8.63B |
| Current Assets | Q2 2025 · Sep 30, 2024 | $10.19B |
| Total Assets | Q2 2025 · Mar 31, 2025 | $41.98B |
| Total Assets | Q2 2025 · Sep 30, 2024 | $44.25B |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $0.86 |
| Eps Diluted | Q2 2025 · Mar 31, 2025 | $1.88 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.87 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $1.12 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $0.86 |
| Eps Basic | Q2 2025 · Mar 31, 2025 | $1.89 |
| Eps Basic restated | Q2 2025 · Mar 31, 2024 | $0.88 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $1.12 |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 574.1M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 573.7M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $175M |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $600M |
| Capex | Q2 2025 · Mar 31, 2024 | $159M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $1.16B |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $1.3B |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $2.57B |
| Net Income | Q2 2025 · Mar 31, 2024 | $501M |
| Net Income | Q2 2025 · Mar 31, 2024 | $643M |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $2.09B |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $4.29B |
| Revenue | Q2 2025 · Mar 31, 2024 | $4.38B |
| Revenue | Q2 2025 · Mar 31, 2024 | $8.49B |